Proteome Sciences PLC operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Proteome Sciences PLC with three other
companies in this sector in the United Kingdom:
Midatech Pharma PLC
sales of £1.38 million [US$1.72 million]
of which 63%
was Pipeline R&D),
Avacta Group Plc
(£1.81 million [US$2.26 million]
of which 76%
was Animal Health), and
Oxford Pharmascience Group PLC
(£749,000.00 [US$935,081.56 ]
of which 100%
was Delivery systems).
During the year ended December of 2015, sales at
Proteome Sciences PLC were £1.88 million (US$2.35 million).
increase of 20.6%
versus 2014, when the company's sales were £1.56 million.
Despite this increase, sales are still
below the level achieved in 2013, when Proteome Sciences PLC
reported sales of £2.14 million.